It is a healthcare public limited company based in Noida, Uttar Pradesh, India, established in 2019.
2019 | Noida, Uttar Pradesh, India | ActiveJubilant Therapeutics India Limited, a active public limited company, was established on 20 March 2019 in Noida, Uttar Pradesh, India. Engaging in oncology clinics & cancer treatment within the professional, scientific and technical sector, it holds CIN: U74994UP2019PLC114901. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹86.65 Cr and a paid-up capital of ₹86.65 Cr.
Employing 13 professional, Its leadership includes Sanjay Gupta (Director), Sridharan Rajagopal (Whole-Time Director), Shyam Pattabiraman (Director). Past directors included Rajesh Kumar Srivastava, Sanjay Gupta, Arvind Chokhany. Its latest AGM occurred on 28 August 2025, with the balance sheet filed on 31 March 2025. It is based at 1-A Sector 16 A, Noida, Uttar Pradesh, 201301.
U74994UP2019PLC114901
114901
20 March 2019
₹86.65 Cr
₹86.65 Cr
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Jubilant Therapeutics India Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjay Gupta | Director | 16 Jul 2021 | Current |
| Sridharan Rajagopal | Whole-Time Director | 15 May 2019 | Current |
| Shyam Pattabiraman | Director | 08 Sep 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 29 Jun 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2021 | Past |
| Pramod Abcsdd | Director | 01 Apr 2020 | Past |
| Pramod Abcsdd | Director | 17 Sep 2019 | Past |
| Pramod Abcsdd | Additional Director | 17 Jul 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Jubilant Therapeutics India Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 14.08% increase. The company also saw a substantial improvement in profitability, with a 63.79% increase in profit. The company's net worth Soared by an impressive increase of 20.61%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Jubilant Therapeutics India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Jubilant Therapeutics India has a workforce of 13 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Jubilant Therapeutics India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jubilant Therapeutics India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Jubilant Therapeutics India Limited last Annual general meeting of members was held on 28 Aug 2025 as per latest MCA records. was recorded as a recent event.
The activity Jubilant Therapeutics India Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur. was completed.
Progress on Sanjay Gupta was appointed as a Director was appointed as a Director on 16 Jul 2021 & has been associated with this company since 4 years 6 months . was documented.
Progress on Shyam Pattabiraman was appointed as a Director was appointed as a Director on 08 Sep 2020 & has been associated with this company since 5 years 4 months . was documented.
Progress on Anil Sharma was appointed as a Company Secretary was appointed as a Company Secretary on 18 Sep 2019 & has been associated with this company since 6 years 4 months . was documented.
Progress on Arun Kumar Sharma was appointed as a CFO was appointed as a CFO on 18 Sep 2019 & has been associated with this company since 6 years 4 months . was documented.
The CIN of Jubilant Therapeutics India Limited is U74994UP2019PLC114901.
Jubilant Therapeutics India Limited is headquartered at 1-A Sector 16 A, Noida, Uttar Pradesh, 201301.
Jubilant Therapeutics India Limited was incorporated on 20 March 2019.
The current directors of Jubilant Therapeutics India Limited are
The primary industry of Jubilant Therapeutics India Limited is Professional, Scientific And Technical.
Jubilant Therapeutics India Limited is unlisted.
The authorized capital of Jubilant Therapeutics India Limited is ₹86.65 Cr, and the paid-up capital is ₹86.65 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX